Molina Healthcare Misses Q2 Earnings but Lifts Full-Year Outlook
MOH sits 71% above its 52-week low of $121.06.
Summary
Molina Healthcare's Q2 earnings fell 76% on lower membership and higher medical costs, but the company raised its full-year adjusted EPS guidance to at least $5.25, citing stabilizing Medicaid trends.
Key Events · Earnings and Guidance · MOH
-
Q2 Earnings Miss
GAAP EPS of $1.19 missed expectations, down 75% from $4.75 a year ago. Adjusted EPS of $1.51 also fell sharply from $5.48.
-
Full-Year Guidance Raised
Adjusted EPS guidance increased by $0.25 to at least $5.25, driven by Medicaid performance. GAAP EPS guidance set at at least $2.15.
-
Revenue Decline
Premium revenue fell 6% to $10.2 billion, reflecting a 14% drop in membership to 4.9 million, partially offset by rate updates.
-
Medical Costs Pressure
Consolidated MCR rose to 92.2% from 90.4%, with Medicaid MCR at 92.7% and Marketplace MCR at 88.9%, both above expectations.
Analysis · MOH · Finance
A 76% plunge in Q2 net income to $60 million, or $1.19 per share, underscores the pressure from a 6% decline in premium revenue and a medical care ratio that climbed to 92.2%. Yet the company raised its full-year 2026 adjusted EPS guidance by $0.25 to at least $5.25, signaling confidence that Medicaid rate pressures are stabilizing. The stock is likely to react to the mixed message: near-term earnings deterioration versus a brighter 2027 outlook.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 36.6% of the 1018 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MOH was trading at $206.83 on NYSE in the Finance sector, with a market capitalization of approximately $11.9B. The 52-week trading range was $121.06 to $244.89. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.